Kexing Biopharm Participates in Saudi Arabia (Riyadh) - China (Shenzhen) Medical Device Industry Promotion Conference
Comunicato Precedente
Comunicato Successivo
As a pioneer in Shenzhen's pharmaceutical and medical device overseas ventures, Kexing Biopharm showcased the company's "Innovation + Internationalization" strategic direction and the strengths of its overseas platform at the conference. It also conveyed the core mission of the Shenzhen Pharmaceutical and Medical Device Industry Overseas Expansion Consortium - "collaborative expansion overseas, sharing opportunities" - attracting significant attention from local Saudi resources.
Leveraging this promotion conference, Kexing Biopharm also formally signed an agreement with a local Saudi regulatory consulting firm.
Meanwhile, in Saudi Arabia, Kexing Biopharm currently has several cooperate overseas products, including infliximab, bevacizumab, and adalimumab, under registration and approval.
In the future, Kexing Biopharm will collaborate with members of the Shenzhen Pharmaceutical and Medical Device Industry Overseas Expansion Consortium and partners to continuously deepen its layout in the Saudi and broader Middle East markets, accelerate the rapid launch of multiple products under registration, and contribute Kexing's strengths to the internationalization of China's pharmaceutical and medical device industry through professional, compliant, and localized operations.
View original content:https://www.prnewswire.co.uk/news-releases/kexing-biopharm-participates-in-saudi-arabia-riyadh---china-shenzhen-medical-device-industry-promotion-conference-302588767.html
Ufficio Stampa
PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom




